129 related articles for article (PubMed ID: 1661266)
21. EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients.
Bower M; Newlands ES; Holden L; Short D; Brock C; Rustin GJ; Begent RH; Bagshawe KD
J Clin Oncol; 1997 Jul; 15(7):2636-43. PubMed ID: 9215835
[TBL] [Abstract][Full Text] [Related]
22. Combination chemotherapy with methotrexate, etoposide, and actinomycin D for high-risk gestational trophoblastic tumors.
Matsui H; Suzuka K; Iitsuka Y; Seki K; Sekiya S
Gynecol Oncol; 2000 Jul; 78(1):28-31. PubMed ID: 10873405
[TBL] [Abstract][Full Text] [Related]
23. Chemotherapy-resistant gestational trophoblastic neoplasia treated successfully with cisplatin, etoposide, and bleomycin.
Willemse PH; Aalders JG; Bouma J; Sleijfer DT
Obstet Gynecol; 1988 Mar; 71(3 Pt 2):438-40. PubMed ID: 2450325
[TBL] [Abstract][Full Text] [Related]
24. Effects of multiagent chemotherapy and independent risk factors in the treatment of high-risk GTT--25 years experiences of KRI-TRD.
Kim SJ; Bae SN; Kim JH; Kim CT; Han KT; Lee JM; Jung JK
Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S85-96. PubMed ID: 9833620
[TBL] [Abstract][Full Text] [Related]
25. A novel strategy using G-CSF to support EMA/CO for high-risk gestational trophoblastic disease.
Hartenbach EM; Saltzman AK; Carter JR; Twiggs LB
Gynecol Oncol; 1995 Jan; 56(1):105-8. PubMed ID: 7529741
[TBL] [Abstract][Full Text] [Related]
26. Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy.
Lurain JR; Singh DK; Schink JC
J Reprod Med; 2006 Oct; 51(10):767-72. PubMed ID: 17086804
[TBL] [Abstract][Full Text] [Related]
27. Remission of refractory gestational trophoblastic disease in the brain with ifosfamide, carboplatin, and etoposide (ICE): first report and review of literature.
Piamsomboon S; Kudelka AP; Termrungruanglert W; Van Besien K; Edwards CL; Lifshitz S; Schomer DF; Champlin R; Mante RP; Kavanagh JJ; Verschraegen CF
Eur J Gynaecol Oncol; 1997; 18(6):453-6. PubMed ID: 9443008
[TBL] [Abstract][Full Text] [Related]
28. Poor-prognosis gestational trophoblastic disease: an update.
Surwit EA; Alberts DS; Christian CD; Graham VE
Obstet Gynecol; 1984 Jul; 64(1):21-6. PubMed ID: 6204257
[TBL] [Abstract][Full Text] [Related]
29. Gestational trophoblastic disease.
Berkowitz RS; Goldstein DP
Cancer; 1995 Nov; 76(10 Suppl):2079-85. PubMed ID: 8635004
[TBL] [Abstract][Full Text] [Related]
30. EMACO in high risk gestational trophoblast disease--the Australian experience. Gestational Trophoblast Subcommittee, Clinical Oncological Society of Australia.
Quinn M; Murray J; Friedlander M; Steigrad S; Khoo S; Marsden D; Hammond I; Jobling T
Aust N Z J Obstet Gynaecol; 1994 Feb; 34(1):90-2. PubMed ID: 8053886
[TBL] [Abstract][Full Text] [Related]
31. [Therapeutic evaluation of cisplatin, etoposide, and bleomycin chemotherapy regimen in high-risk gestational trophoblastic neoplasia].
Song SQ; Zhang GN
Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):571-6. PubMed ID: 23141175
[TBL] [Abstract][Full Text] [Related]
32. Developments in chemotherapy for medium- and high-risk patients with gestational trophoblastic tumours (1979-1984).
Newlands ES; Bagshawe KD; Begent RH; Rustin GJ; Holden L; Dent J
Br J Obstet Gynaecol; 1986 Jan; 93(1):63-9. PubMed ID: 3002420
[TBL] [Abstract][Full Text] [Related]
33. Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000.
McNeish IA; Strickland S; Holden L; Rustin GJ; Foskett M; Seckl MJ; Newlands ES
J Clin Oncol; 2002 Apr; 20(7):1838-44. PubMed ID: 11919242
[TBL] [Abstract][Full Text] [Related]
34. Management of resistant gestational trophoblastic tumors.
Newlands ES; Bower M; Holden L; Short D; Seckl MJ; Rustin GJ; Begent RH; Bagshawe KD
J Reprod Med; 1998 Feb; 43(2):111-8. PubMed ID: 9513872
[TBL] [Abstract][Full Text] [Related]
35. EP-EMA regimen (etoposide and cisplatin with etoposide, methotrexate, and dactinomycin) in a series of 18 women with gestational trophoblastic neoplasia.
Han SN; Amant F; Leunen K; Devi UK; Neven P; Vergote I
Int J Gynecol Cancer; 2012 Jun; 22(5):875-80. PubMed ID: 22635033
[TBL] [Abstract][Full Text] [Related]
36. The management of high-risk gestational trophoblastic tumours (GTT).
Newlands ES; Bower M; Holden L; Short D; Brock C; Rustin GJ; Begent RH; Bagshawe KD
Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S65-70. PubMed ID: 9833617
[TBL] [Abstract][Full Text] [Related]
37. Management of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine chemotherapy.
Cyriac S; Rajendranath R; Sridevi V; Sagar TG
J Reprod Med; 2011; 56(5-6):219-23. PubMed ID: 21682117
[TBL] [Abstract][Full Text] [Related]
38. [Study on the indication of surgical resection of pulmonary metastasis of malignant trophoblastic tumor].
Zhang Y; Xiang Y; Ren T; Wan XR; Yang XY
Zhonghua Fu Chan Ke Za Zhi; 2005 Feb; 40(2):83-6. PubMed ID: 15840284
[TBL] [Abstract][Full Text] [Related]
39. Persistent gestational trophoblastic disease: results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomycin) as second-line therapy for low risk disease.
Dobson LS; Lorigan PC; Coleman RE; Hancock BW
Br J Cancer; 2000 May; 82(9):1547-52. PubMed ID: 10789722
[TBL] [Abstract][Full Text] [Related]
40. Primary oral etoposide therapy in gestational trophoblastic disease. An update.
Wong LC; Choo YC; Ma HK
Cancer; 1986 Jul; 58(1):14-7. PubMed ID: 3011237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
